Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CBD Luxe is a wellness and nutraceutical company specializing in high-quality cannabidiol (CBD) products with advanced delivery systems. Founded in 2015 and based in Golden, Colorado, the company is known for its innovative metered-dose inhalers (MDIs) that provide precise dosing of micellized full-spectrum hemp oil. Their product portfolio includes 'Be Active,' 'Be Well,' 'Be Calm,' and 'Be Clear' lines, targeting indications such as chronic pain, anxiety, inflammation, and sleep disorders. CBD Luxe utilizes nanotechnology to create water-soluble, nano-particulate CBD, enhancing bioavailability and absorption compared to traditional oils. The company emphasizes organic, non-GMO ingredients and pharmacological standards in its manufacturing processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CBD Luxe.